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Abstract 
Background: 2,3-Butanediol (2,3-BD) with low toxicity to microbes, could be a promising alternative for biofuel 
production. However, most of the 2,3-BD producers are opportunistic pathogens that are not suitable for industrial-
scale fermentation. In our previous study, wild-type Bacillus subtilis 168, as a class I microorganism, was first found to 
generate only d-(−)-2,3-BD (purity >99 %) under low oxygen conditions.
Results: In this work, B. subtilis was engineered to produce chiral pure meso-2,3-BD. First, d-(−)-2,3-BD production 
was abolished by deleting d-(−)-2,3-BD dehydrogenase coding gene bdhA, and acoA gene was knocked out to pre-
vent the degradation of acetoin (AC), the immediate precursor of 2,3-BD. Next, both pta and ldh gene were deleted to 
decrease the accumulation of the byproducts, acetate and l-lactate. We further introduced the meso-2,3-BD dehydro-
genase coding gene budC from Klebsiella pneumoniae CICC10011, as well as overexpressed alsSD in the tetra-mutant 
(ΔacoAΔbdhAΔptaΔldh) to achieve the efficient production of chiral meso-2,3-BD. Finally, the pool of NADH availabil-
ity was further increased to facilitate the conversion of meso-2,3-BD from AC by overexpressing udhA gene (coding 
a soluble transhydrogenase) and low dissolved oxygen control during the cultivation. Under microaerobic oxygen 
conditions, the best strain BSF9 produced 103.7 g/L meso-2,3-BD with a yield of 0.487 g/g glucose in the 5-L batch 
fermenter, and the titer of the main byproduct AC was no more than 1.1 g/L.
Conclusion: This work offered a novel strategy for the production of chiral pure meso-2,3-BD in B. subtilis. To our 
knowledge, this is the first report indicating that metabolic engineered B. subtilis could produce chiral meso-2,3-BD 
with high purity under limited oxygen conditions. These results further demonstrated that B. subtilis as a class I micro-
organism is a competitive industrial-level meso-2,3-BD producer.
Keywords: Metabolic engineering, Meso-2,3-butanediol, d-(−)-2,3-butanediol, Bacillus subtilis, Cofactor engineering
© 2016 Fu et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
2,3-Butanediol (2,3-BD) is an important platform com-
pound, and its derivative products are also promising 
valuable chemicals due to their extensive industrial appli-
cations [1, 2]. 2,3-BD can exist in three isomeric forms: 
d-(−)-, L-(+)- and meso-, and the chiral stereoisomers 
of 2,3-BD can be used as the precursor for the synthesis 
of various chiral compounds or intermediates, which 
can increase the value of the product [3]. Considering 
the high cost in chemical synthesis and separation steps 
[3], chiral pure 2,3-BD stereoisomers produced by engi-
neered strains have gained much more interest in recent 
years.
Microorganisms can produce a mixture of 2,3-BD ste-
reoisomers [4]. The ratio varies dramatically depending 
on the species, and especially the fermentation condi-
tions such as oxygen-diluted rate, temperature, pH, and 
substrate type [5]. In the recent years, research interest 
in microbial 2,3-BD production has increased signifi-
cantly. Klebsiella pneumoniae [6, 7], K. oxytoca [8, 9], 
and Enterobacter aerogenes [10–12] are considered to be 
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absolutely unbeatable in terms of 2,3-BD production effi-
ciency, which can produce a mixture of meso- and L-(+)-
stereoisomers of 2,3-BD with a ratio of approximately 9:1 
[2]. Serratia marcescens [13, 14] is also considered to be 
a promising microorganism that can produce meso- and 
d-(−)- stereoisomers of 2,3-BD (primarily meso-2,3-BD). 
Recently, Bacillus amyloliquefaciens was engineered to 
produce 132.9 g/L 2,3-BD with a productivity of 2.95 g/
(L  h) form glucose [15], and 102.3  g/L from biodiesel-
derived glycerol [16]. However, all the above mentioned 
strains are pathogenic microorganisms [1], which might 
be hazardous to human use and increase the cost of 
industrial-scale production. As for industrially friendly 
hosts, Escherichia coli was optimized to produce 73.8 g/L 
meso-2,3-BD with a yield of 0.41  g/g glucose [17], and 
54  g/L meso-2,3-BD from glucose and xylose mixture 
with a productivity of 0.45 g/(L h) using biomass-induc-
ible chromosome-based expression system [18]. In a 
recent study, E. coli was engineered to produce d-(−)-
2,3-BD with a titer of 115  g/L with high purity [19]. In 
addition, Saccharomyces cerevisiae was engineered to 
produce 72.9  g/L from glucose with a yield of 0.41  g/g 
glucose [20], and more than 100 g/L d-(−)-2,3-BD from a 
mixture of glucose and galactose in up to 300 h [21].
Bacillus subtilis, which was granted GRAS (generally 
regarded as safe) status by the US Food and Drug Admin-
istration [22], has been applied as a model system for 
researchers on the aspects of biochemistry [23], genet-
ics, and physiology of gram-positive bacteria. It has long 
been widely used for the environmental, medical, and 
industrial applications [24]. In our recent study, wild-type 
B. subtilis 168 was found to generate only d-(−)-2,3-BD 
(purity >99 %) under low oxygen conditions [25].
As the direct precursor of 2,3-BD, acetoin (AC) forma-
tion from pyruvate was catalyzed in a two-step reaction 
by acetolactate synthase and acetolactate decarboxylase 
in B. subtilis, coded by alsS and alsD, respectively [26]. 
It was indicated that although the LysR-type transcrip-
tional regulator AlsR protein (coded by alsR) positively 
regulated the alsSD operon [27, 28] in B. subtilis, it indi-
rectly regulated the expression of bdhA (encoding 2,3-BD 
dehydrogenase/AC reductase) [29]. The biodegradation 
of AC was catabolized by the AC dehydrogenase enzyme 
system, and its core subunit encoded by acoA affects the 
dehydrogenase complex activity significantly [30]. AC 
was reduced to 2,3-BD by 2,3-BD dehydrogenase (BDH), 
also called AC reductase (AR), with oxidation of NADH 
to NAD+. The regulation facilitating increased NADH 
availability and NADH/NAD+ ratio played a key role 
for the enhanced 2,3-BD/AC production [25, 31]. In our 
previous study, the production of AC was enhanced by 
insertional inactivation of the acoA and pta genes, and 
overexpression of alsS and alsD [32, 33]. In this work, 
the lactate dehydrogenase coding gene ldh was deleted 
to reduce the byproduct lactate and increase the NADH 
availability for enhanced meso-2,3-BD production.
Dissolved oxygen (DO) level had been shown to have 
a profound effect on the product distribution, with AC 
being excreted with DO greater than 100 parts per bil-
lion (ppb) and 2,3-BD, less than 100 ppb [34]. The prod-
uct concentration ratio (2,3-BD to AC) changed rapidly 
in the 80–90  ppb range [35]. The expressions of alsS 
and alsD were increased under anaerobic conditions 
compared with aerobic condition, indicating that 2,3-
BD might be accumulated to a higher level when DO 
decreased to a certain degree [29, 36]. In a recent study, 
the initial concentration of corn steep liquor had remark-
able effects on both 2,3-BD production and the ratio of 
2,3-BD to AC [37].
In this work, a series of mutant strains were con-
structed to improve the yield and production of meso-
2,3-BD step by step, including disruption of all the target 
genes (acoA, bdhA, pta, and ldh), introduction of meso-
2,3-butadediol coding gene budC from K. pneumoniae 
CICC10011, and overexpressions of alsS and alsD in 
2,3-BD synthetic pathway (Fig.  1) by means of a modi-
fied marker-less genetic manipulation system [38, 39]. 
In addition, deletion of ldh and overexpression of udhA 
were employed to improve the availability of NADH 
for AC reductase (AR). Batch cultures under micro-
aerobic conditions were employed to investigate the 
Fig. 1 The meso-2,3-BD biosynthetic pathway in B. subtilis. Enzymes 
overexpressed or introduced are underlined and depicted in green, 
and those interrupted are shown in red with a cross. Expanded names 
of enzymes and their coding genes: ALS acetolactate synthase, alsS; 
ALD acetolactate decarboxylase, alsD; ACK acetate kinase, ack; ALDH 
acetaldehyde dehydrogenase, adh; ADH alcohol dehydrogenase, 
ack; LDH lactate dehydrogenase, ldh; PDH pyruvate dehydrogenase, 
pdhABCD; PTA phosphotransacetylase, pta; PYC pyruvate carboxylase; 
E1, d-(−)-butanediol dehydrogenase (EC 1.1.1.4), bdhA; E2, L-(+)-
butanediol dehydrogenase (EC 1.1.1.76), budC
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performances of these genetically modified B. subtilis 
mutants. Finally, strain BSF9 produced 103.7  g/L meso-
2,3-BD (purity >99 %) with a yield of 0.487 g/g glucose in 
fed-batch experiment.
Results and discussion
Increasing metabolic flux in 2,3‑BD pathway by reducing 
AC consumption and eliminating byproducts
With the purpose of increasing AC, the supply of the 
direct substrate of 2,3-BD, acoA was disrupted in BSF1 
(B. subtilis 168Δupp), yielding BSF2. The growth and 
products of the mutants were characterized and are sum-
marized in Table 1. When glucose was depleted, the dele-
tion led to a slight increase of total production of 2,3-BD 
and AC in BSF2 (2.84 g/L BD + 1.03 g/L AC) compared 
to that of BSF1 (2.70 g/L BD + 0.82 g/L AC). Unlike pre-
vious report [30] in which AC was mainly consumed by 
AC dehydrogenase enzyme pathway after glucose was 
exhausted, this result demonstrated that partial AC had 
already been consumed before glucose was exhausted. 
After glucose was exhausted, the deletion of acoA also 
reduced the conversion of AC to acetate as previously 
reported [26]. BSF1 consumed about 1.2 g/L AC, as well 
as produced about 0.3 g/L acetate from 60 h to 96 h (data 
not shown). By analysis of extracellular metabolites by 
HPLC, we found that acetate was the main product of 
the oxidative dissimilation of AC in B. subtilis, which is 
consistent with Lopez et al.’s study on the direct oxidative 
cleavage of AC [40]. In the case of the acoA-deleted strain 
BSF2 during this period, however, the concentration 
of AC was reduced by only 0.25 g/L (2.8 mM) (data not 
shown). These results implied that the deletion of acoA 
could lead to the increasing accumulation of AC, and fur-
ther increase in its direct production of 2,3-BD.
As shown in Table  1, a small amount of acetate had 
been detected in the media of strains BSF2 when glucose 
was depleted, while lactate and succinate accumulated 
with maximum concentrations of 0.36 and 0.09  g/L, 
respectively. To eliminate the accumulation of byprod-
ucts, acetate and lactate, pta (coding phosphate acetyl-
transferase) and ldh (coding l-lactate dehydrogenase) 
were deleted, respectively. Inactivation of pta had almost 
no effect on acetate reduction of BSF4 (0.14 ± 0.01 g/L) 
compared with BSF3 (bdhA deleted in BSF2 for abolish-
ing of d-(−)-2,3-BD) (0.17 ± 0.01 g/L), indicating there 
might be other major acetate or acetyl-phosphate syn-
thetic pathways in B. subtilis [41]. However, the biomass 
decreased from 0.898  g/L DCW for BSF3 to 0.828  g/L 
DCW for BSF4, while the glucose consumption rate 
slightly decreased from 0.233 g/(L h) of BSF3 to 0.222 g/
(L  h) of BSF4. The disruption of ldh abolished lactate 
accumulation of BSF5; however, it drastically increased 
the formations of acetate and succinate to 0.71 and 
0.29  g/L, respectively. The increasing concentrations of 
acetate and succinate might presumably have resulted 
from an unknown regulatory mechanism that affected 
the other acetate synthesis pathway of ldh-deleted 
mutant BSF5. In our previous study, we observed that 
bdhA deletion resulted in a lower biomass (0.960 g/L for 
BSF1 versus 0.898  g/L for BSF3) and a slower glucose 
consumption rate [0.270 g/(L h) for BSF1 versus 0.233 g/
(L h) for BSF3]. Here, we found that the knockout of ldh 
in bdhA-deleted mutant BSF4 further decreased the bio-
mass formation (from 0.828 to 0.814  g/L) and glucose 
consumption rate [from 0.222 to 0.208  g/(L  h)]. It was 
also reported that deletion of ldh in B. subtilis resulted 
in drastic growth reduction under anaerobic condi-
tions [42]. All these results might be ascribed to the 
fact that blocking the biosynthesis pathways of reducing 
metabolites caused the imbalance of reducing power to 
some extent, which was demonstrated by the intracel-
lular NADH/NAD+ analysis (Fig. 2). The NADH/NAD+ 
level increased from 0.61 for BSF1 to 0.71 for BSF4, and 
further increased to 0.83 for BSF5. For all the strains 
containing ldh, lactate was accumulated to its high-
est concentration when glucose was depleted and was 
quickly reused when glucose was exhausted, indicating 
that lactate might be a direct carbon source for B. sub-
tilis after the glucose was depleted in minimal medium. 
Although deletion of ldh did not increase metabolic flux 
in 2,3-BD pathway, it could increase the NADH/NAD+ 
ratio for further conversion of AC to 2,3-BD, as the 
NADH availability was the key factor for 2,3-BD produc-
tion [25].
Enhancing AC synthetic pathway
For the purpose of increasing metabolic flux in AC syn-
thetic pathway, an additional copy of alsSD mediated 
by a strong promoter P43 [43] was integrated into the 
chromosome of BSF5 at bdhA locus, yielding BSF6. The 
additional copies of alsS and alsD in BSF6 were consti-
tutively expressed without the regulation of alsR [29, 36]. 
The yield of AC of BSF6 was almost unchanged; however, 
concentrations of acetate and succinate of BSF6 (0.61 g/L 
and 0.20  g/L, respectively) decreased slightly compared 
to those of BSF5 (0.71 and 0.29 g/L, respectively). Indeed, 
the overexpressions of alsS and alsD did not contribute 
much to AC production (3.71 g/L of BSF5 versus 3.88 g/L 
of BSF6), probably because the activities of the two 
enzymes in B. subtilis were high enough, and the alsS–
alsD pathway played the dominating role in the metabo-
lism. As a result, the most competitive strain BSF6 with 
the highest AC production (Table 1), high NADH/NAD+ 
ratio, and abolishing of d-(−)-2,3-BD accumulation was 
used as the parent strain for further construction of 
meso-2,3-BD producer.
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Introducing meso‑2,3‑BD dehydrogenase for chiral 
meso‑2,3‑BD production
To produce chiral meso-2,3-BD, budC from Klebsiella 
pneumoniae CICC10011 was introduced in BSF5 and 
BSF6, yielding BSF7 and BSF8, respectively. BSF7 pro-
duced 2.85  g/L meso-2,3-BD and 0.91  g/L AC, while 
alsSD-overexpressing strain BSF8 produced slightly more 
meso-BD and AC (2.90 and 1.10  g/L, respectively). As 
the major byproducts, the concentrations (Table  1) of 
acetate and succinate of BSF8 were slightly lower than 
those of BSF7, which was similar to the results of BSF6 
with alsSD overexpressed. The glucose consumption rate 
was partially restored by overexpression of budC, indicat-
ing that excess NADH, which might impact the glucose 
consumption rate of BSF6, was consumed in the reaction 
of 2,3-BD formation. However, there still remained 0.91 
and 1.1 g/L AC when glucose was depleted in the fermen-
tation broths of BSF7 and BSF8, respectively, indicating 
more NADH should be provided for converting AC to 
2,3-meso-BD.
It was worth noting that BSF3 produced less acetate 
and succinate, and showed faster glucose consumption 
rate than BSF5, although with 0.44 g/L lactate being pro-
duced when glucose was depleted. Considering the mini-
mum byproducts’ yields (about 0.011 mol succinate/mol 
glucose, 0.054  mol acetate/mol glucose, and 0.088  mol 
lactate/mol glucose) of this strain, budC was introduced 
into it, yielding BSF17. For all the mutants that could 
produce d-(−)- or meso-2,3-BD as shown in Table 2, 2,3-
BD was transformed into AC after glucose was depleted. 
Interestingly, the decreased amount of meso-2,3-BD pro-
duced by BSF17 (from 2.93 g/L at 37 h to 1.56 g/L at 60 h) 
was less than that of d-(−)-2,3-BD produced by BSF18 
(B. subtilis 168ΔuppΔacoAΔbdhA; pHP13-P43-bdhA) (Fu 
et al. [25]) (3.19 g/L at 37 h–0.11 g/L at 60 h) under the 
same condition, which suggested that AR coded by budC 
might have a less tendency to be producing AC than AR 
that was coded by bdhA after glucose was completely 
consumed.
Improving NADH supply and distribution to convert more 
AC to meso‑2,3‑BD
In order to provide more NADH for converting AC to 
meso-2,3-BD, udhA was introduced into BSF6 by vec-
tor pPSDBUE (overexpressing alsS, alsD, budC, and 
udhA genes), yielding BSF9. Noticeably, BSF9 exhibited 
a faster glucose consumption rate than BSF4-8. With 
the increased NADH availability, a maximum titer of 
3.56  g/L meso-2,3-BD (purity >99  %) was produced by 
BSF9, which was 22.8  % higher than that produced by 
BSF8. Meanwhile, the amount of AC of BSF9 (0.68 g/L) 
was 38.2 % lower than that of BSF8 (1.10 g/L). The con-
version of more AC to meso-2,3-BD by BSF9 implied that 
more NADH was provided for the reaction of 2,3-BD 
formation catalyzed by AR. Although the concentration 
of AC decreased by degrees, there was still a quantity of 
AC (0.68 g/L) left in the fermentation culture of BSF9 due 
to the lack of NADH available, which would be solved by 
reducing the oxygen level in rich medium afterward. In 
addition, both of the byproducts, acetate and succinate, 
accumulated by BSF9 were decreased compared with 
BSF8, which might be caused by an extra copies of alsS 
and alsD in BSF9 compared to BSF8. As expected, BSF9 
exhibited the highest meso-2,3-BD production among all 
the mutants. Noticeably, deleting udhA in E. coli, led to 
significant increases in the NADPH/NADP+ ratio and 
improved the NADPH-dependent xylose reduction [44], 
while in Corynebacterium glutamicum, the expression 
of the pntAB genes (coding a membrane-integral nicoti-
namide nucleotide transhydrogenase PntAB to drive the 
reduction of NADP+ via the oxidation of NADH) from 
E. coli resulted in the conversion of NADH to NADPH, 
which both demonstrated that the transhydrogenase had 
been widely used and could be a suitable strategy for 
cofactor engineering [45].
In addition, the pPSDBUE was also introduced into 
BSF3, yielding BSF25. In the absence of pta and ldh dele-
tions, BSF25 showed an increased glucose consumption 
rate, and accumulated less acetate and succinate than 
BSF9 (although producing a small amount of lactate at 
36  h). As shown in Table  1, BSF25 exhibited the fastest 
glucose consumption rate among all the mutants. How-
ever, BSF9 produced less AC and more meso-2,3-BD 
Fig. 2 Changes in the levels of intracellular NADH/NAD+ ratios in dif-
ferent strains. Bacteria were cultivated using a mixture of 100 mL M9 
and 10 g/L glucose in a 250-mL flask kept agitated at a speed of 
100 rpm and 37 °C. The intracellular NADH and NAD+ were extracted 
after 30 h. Data show average values and standard deviations of 
triplicate experiments
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(3.56 g/L) than that of BSF25 (3.28 g/L), as the result of 
the further increased NADH/NAD+ ratio (Fig. 2) in BSF9 
by deleting ldh. Remarkably, the AR activities in BSF17, 
BSF25, and BSF9 were 511.5 ± 104.4, 488.0 ± 25.3, and 
367.8 ± 27.1 nmol/min−1 mg cell protein−1, respectively, 
in M9 medium with 10 g/L glucose in microaerobic con-
ditions at 34 h, which were at the same level.
The overall strategy used to increase the pool of 
NADH available and reduce its consumption (Fig.  3) 
was as follows. The udhA gene was overexpressed in 
BSF25 and BSF9, transforming NADPH [produced by 
the pentose phosphate pathway (PPP)] to NADH sup-
ply. To reduce the consumption of NADH in lactate 
synthetic pathway, ldh was deleted to block the pathway, 
and the deletion had increased 2,3-BD yield and titer of 
BSF9 (Δldh) compared with BSF25 in the M9 medium. 
Afterward, high volume and low agitation speed were 
adopted to reduce the DO level. Therefore, the wastage 
of [H] in NADH produced by Embden Meyerhof Par-
nas pathway (EMP), tricarboxylic acid cycle (TCA) and 
from the reoxidation of excess NADPH, could be con-
siderably reduced in the respiratory chain. Furthermore, 
rich medium with more reducing substrate could allow 
higher NADH availability and cell density, and hence the 
LBR medium was available to be used subsequently, thus 
leading to the improved 2,3-BD production in this study.
Table 2 Long-term fermentation of  B. subtilis strains in  the LB(Y) medium supplemented with  105  g/L glucose 
under microaerobic condition
Bacteria were cultivated using a mixture of 100-mL LBR medium and 10.5 % glucose in a 250-mL flask kept agitated at a speed of 100 rpm and 37 °C; Data are average 
values and standard deviations of triplicate experiments. D, d-(−)-2,3-BD; M, meso-2,3-BD
a The CDW was calculated using the relationship: “CDW = OD600*0.325”
b These metabolites were measured at 216 h
Strain CDWa (g/L) 
(at 216 h)

















BSF1 3.10 ± 0.38 40.84 ± 1.25(D) 3.47 ± 0.49 0.63 ± 0.11 1.19 ± 0.15 0.10 ± 0.02 87.3 ± 2.1 0.404 0.189 0.936
BSF9 3.82 ± 0.41 50.16 ± 0.52(M) 3.35 ± 0.79 0.62 ± 0.11 0.04 ± 0.00 0.16 ± 0.02 104.3 ± 0.5 0.483 0.232 0.962
BSF25 4.17 ± 0.22 49.59 ± 0.23(M) 2.66 ± 0.48 0.34 ± 0.04 1.17 ± 0.17 0.11 ± 0.02 105.0 ± 0.0 0.486 0.230 0.945
Fig. 3 Metabolic distribution of reducing power [H] in B. subtilis mutants. The arrows represent the delivery of the [H] in NADH, and the dashed 
arrows represent the creation of the [H]. The acetoin synthesis and breakdown pathway are indicated in the oval frame. Overexpressed genes are 
underlined. Disrupted pathway steps ar indicated by broken arrows
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Fermentation in rich medium to enhance 2,3‑BD 
production in agitating flask
The unsatisfactory 2,3-BD productivity and yield in M9 
medium might be caused by two reasons. First, the bio-
mass was very low in the stationary phase in M9 medium, 
resulting in a low overall glucose consumption rate and 
2,3-BD productivity. Second, a high proportion of NADH 
was wasted in the respiratory chain, leaving considerable 
AC in the fermentation broth, and therefore the 2,3-BD 
yield appeared to be low.
In order to investigate the enhanced 2,3-BD production 
in the medium containing enough reducing substances, 
we tried to use LBR medium with 105  g/L glucose in a 
batch flask fermentation process (Table 2). As expected, 
both BSF25 (49.59  g/L, 94.5  % of the theoretical maxi-
mum yield) and BSF9 (50.16 g/L, 96.2 % of the theoretical 
maximum yield) showed a high meso-2,3-BD production 
and yield. Remarkably, the two strains produced almost 
the same amount of meso-2,3-BD, probably because 
of the sufficient availability of the reducing substances 
provided by the rich medium LBR. In addition, it was 
worth noting that the 2,3-BD production of BSF1 (with-
out udhA introduced) was not satisfactory, possibly due 
to the low glucose consumption rate or the imbalance 
of the reducing capacity under microaerobic condition 
(Table 2).
High 2,3‑BD production achieved by optimization 
of oxygen supply in 5‑L fermentor and its advantages 
using B. subtilis as the producer
To improve the meso-2,3-BD titer and productivity and 
achieve a more appropriate
fermentation condition, batch fermentation was con-
ducted with different DO levels. As shown in Fig. 4a, b, 
and c, the aeration rate strongly influenced extracellular 
metabolite concentrations during 2,3-BD fermentation. It 
was indicated that the meso-2,3-BD yield increased from 
0.164 to 0.489 g/g glucose as the aeration rate decreased 
from 1–0.02 VVM (Fig.  4d). Bacillus subtilis was con-
sidered to be an aerobic bacterium, and under aerobic 
Fig. 4 Optimization of oxygen supply in 5-L fermentor. BSF9 was cultured in LBR medium with glucose at 37 °C and 300 rpm in a 5-L fermenter 
at different aeration rates. Filled square glucose concentration; Filled circle 2,3-BD concentration; Filled triangle AC concentration; Filled diamond cell 
density, optical density at 600 nm (OD600). Cultivation was carried out at an initial pH of 6.5. Agitation speed was 300 rpm. Batch fermentation with 
aeration rates of a 1 vvm; b 0.5 vvm; c 0.1 vvm; d glucose consumption, meso-2,3-BD production, AC, meso-2,3-BD yield, and AC + BD total yield of 
BSF9 during oxygen-supply optimization in batch fermentation process
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conditions, it could secrete industrial enzymes [24], ribo-
flavin [46, 47], AC [33, 48], etc. However, as for chiral 
meso-2,3-BD production using B. subtilis, limited oxygen 
condition was preferred for the transaction from AC to 
BD. As a result, the aeration rate as low as 0.02 VVM was 
used subsequently to achieve high meso-2,3-BD yield and 
production.
Under the optimized fermentation conditions, a 
final titer of 103.7  g/L meso-2,3-BD (purity >99  %) and 
1.1  g/L AC as the main byproducts were achieved by 
BSF9 (Fig. 5). The meso-2,3-BD productivity was 0.459 g/
(L  h), which was almost twice as much as that in flask 
experiments. No more than 0.2 g/L succinate or acetate 
was produced. No pyruvic, α-ketoglutaric acid, diacetyl, 
and lactate were detected. During the fermentation, the 
biomass increased slowly in the first 50 h and was main-
tained at the level of approximately 5.2  g/L CDW until 
the end. This low oxygen level resulted in a low bio-
mass and a slow glucose consumption rate, which might 
account for the unsatisfactory meso-2,3-BD productiv-
ity. However, no more than 1.1  g/L AC was produced 
under this condition, which not only caused a high yield 
of 0.487 g meso-2,3-BD/g glucose (97.4 % of the theoreti-
cal maximum yield), but also would be beneficial for the 
downstream purification process.
Significantly, even in the absence of the pH control, 
BSF9 could maintain a good stability of 2,3-BD produc-
tion consistently for over 200  h. The pH fell to 5.8 dur-
ing the first 10  h, gradually increased to 6.4 in the next 
24 h, and then maintained at 6.4 until the end of the fer-
mentation, which indicates the robustness of the mutant. 
Overall, the low aeration rate (0.02 VVM) and agitation 
speed (300  rpm), as well as simple fed-batch process, 
could reduce the costs of energy and operation process 
for industrial-level production.
The ability of B. subtilis for efficient 2,3‑BD production 
at higher temperature
Compared to most of 2,3-BD producers which mainly 
functioned below 37 °C (e.g., S. cerevisiae at 30 °C [20, 
21]), B. subtilis could grow well and had the potential 
to produce 2,3-BD efficiently at a higher temperature. 
Considering this possibility, we tested the 2,3-BD pro-
duction ability of BSF9 at 37, 42, 46, and 50 °C, respec-
tively. As shown in Fig.  6, in the minimal medium, 
the titer of meso-2,3-BD was almost unchanged at 
37, 42, and 46  °C, while the meso-2,3-BD productiv-
ity increased when the cultivation temperature was 
increased from 37 to 46  °C. However, the titer and 
productivity at 50  °C decreased by 28.6 and 36.3  % 
compared to those at 37  °C, respectively, which can 
be attributed to the much lower biomass and about 
0.8  g/L acetate produced at this temperature. This 
problem could be got rid of with the addition of a 
small amount of organic nitrogen sources (e.g., 5  g/L 
corn steep liquor powder or yeast power) to obtain a 
satisfactory meso-2,3-BD production and yield. (data 
not shown).
Overall, strain BSF9 exhibited the ability of produc-
ing 2,3-BD efficiently at a higher temperature above 
46  °C, which allowed reduction in cooling costs dur-
ing fermentation process, especially when the ambient 
temperature was relatively high. However, in the case 
of 2,3-BD production at 50 °C, the growth of this strain 
still needs to be improved by adaptive evolution in the 
future study.
Fig. 5 Meso-2,3-BD production from glucose using BSF9 in fed-batch 
fermentation. Filled square glucose concentration; Filled circle 2,3-BD 
concentration; Filled triangle AC concentration; Filled diamond cell 
density, optical density at 600 nm (OD600). Cultivation was carried 
out at an initial pH of 6.5; during the fermentation processes, the pH 
was uncontrolled. Agitation speed was 300 rpm, and aeration rate 
was 0.02 vvm
Fig. 6 Meso-2,3-BD production, biomass, and productivity using 
BSF9 at different fermentation temperatures. BSF9 was cultivated in 
a mixture of 100 mL M9 and 10 g/L glucose in a 250-mL flask kept 
agitated at a speed of 100 rpm
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Phylogenetic tree based on typical amino acid sequences 
of AR in 2,3‑BD producers
The formation mechanisms of 2,3-BD isomers had been 
the subject of much debate [2], and a preferred model for 
the formation of 2,3-BD isomers was proposed in consid-
eration of the existence of different BDHs/ARs [49, 50]. 
To investigate the relationship between different ARs and 
microorganisms, the phylogenetic tree was built based 
on the typical amino acid sequences of AR of part of the 
2,3-BD producers (Fig.  7). The typical AR amino acid 
sequences expressed in B. amyloliquefaciens, P. polymyxa, 
and B. subtilis exhibited remarkable similarity, which was 
consistent with their close relationship in biological evo-
lution. This phenomenon also occurred in the cases of K. 
pneumonia and K. oxytoca. These results suggested that 
the wild-type microorganisms with close relationship in 
biological evolution might possess (at least) one kind of 
AR with high identity of typical amino acid sequence.
B. subtilis had been reported to produce a mixture of 
meso- and d-(−)-2,3-BD for a long time [5]. In our previ-
ous study, wild-type B. subtilis 168 was found generating 
only d-(−)-2,3-BD (purity >99 %) under low oxygen con-
ditions, while in the present study, B. subtilis 168 was first 
successfully engineered to produce chiral meso-2,3-BD 
(purity >99  %). Noticeably, d-(−)-2,3-BD dehydrogenase 
coded by bdhA was thought to be the major AR in B. sub-
tilis, and its deletion abolished 2,3-BD production in early 
stationary phase [28, 51]; however, the other 2,3-BD dehy-
drogenases remained unknown. In a recent study [52], 
meso-2,3-BD dehydrogenase was identified from a strain 
of B. subtilis, and it was suggested that a nonconservative 
amino acid substitution from Asp to Gly of this dehydro-
genase caused the loss of its catalytic function and enzy-
matic activity. This result might further illustrate the fact 
that wild-type B. subtilis 168 generated only d-(−)-2,3-BD 
(purity >99 %). Interestingly, B. licheniformis, which had a 
close relationship with B. subtilis, was found to produce 
d-(−)- and meso-2,3-BD with a ratio of nearly 1:1 [53], 
and a genetically modified strain for d-(−)-2,3-BD pro-
duction was obtained by deleting the meso-2,3-BD dehy-
drogenase coded by budC [54]. It should be noticed that 
the typical amino acid sequence of AR in B. licheniformis 
[d-(−)- and meso-2,3-BD as major products] and that of 
AR K. pneumonia [meso-2,3-BD and L-(+)-2,3-BD with a 
ratio of 9:1] had high similarity, although those two strains 
produced different kinds of 2,3-BD and had a far evolu-
tionary distance between them. Moreover, it had been 
reported that the glycerol dehydrogenase coded by gdh in 
B. licheniformis could catalyze interconversion between 
(3R)-AC and d-(−)-2,3-BD [53], although the protein 
sequence of glycerol dehydrogenase was dissimilar from 
that of AR coded by bdhA in B. subtilis. These results 
inspired the researchers to reinvestigate the chiral config-
uration of 2,3-BD mixtures and the enzymes that catalyze 
the reaction between AC and 2,3-BD isomers.
Conclusions
In summary, the bdhA in B. subtilis 168 was replaced 
by budC from K. pneumonia CICC10011 and resulted 
in chiral meso-2,3-BD production. The production of 
chiral meso-isomer obtained in this work was the high-
est among the reported Bacillus genuses, which were 
excellent candidates for industrial-scale microbial fer-
mentation of meso-2,3-BD. This study provided a deep 
understanding of chiral 2,3-BD metabolism in B. subtilis, 
and a strategy for enhancing the chiral pure 2,3-BD pro-
duction through genetic modification. Moreover, deletion 
of ldh and introduction of udhA, low DO control, and 
additional reducing substrates further enhanced meso-
2,3-BD production, which indicated that the key factor 
for meso-2,3-BD production in B. subtilis was transfor-
mation of AC to 2,3-BD. Finally, 103.7 g/L meso-2,3-BD 
with a yield of 0.974  mol/mol glucose was obtained by 
the optimal strain BSF9 under limited oxygen conditions. 
The simple operation involving, e.g., uncontrolled pH, 
low aeration rate, and low agitation speed, could reduce 
the costs of energy and operational process for industrial-
level production. The fermentation process exhibited 
high yield, titer, and purity of meso-2,3-BD, demonstrat-
ing that B. subtilis as a Class I microorganism was a com-
petitive candidate as a meso-2,3-BD producer and could 
be further developed for its production at industrial level.
Methods
Bacteria strains, media, and growth conditions
All B. subtilis strains used were derived from the wild-
type B. subtilis 168. The strains and plasmids used in this 
work are listed in Table 3.
Fig. 7 The phylogenetic tree based on typical amino acid sequences 
of AR from 14 2,3-BD producers. The sequences were extracted from 
the NCBI protein database by a BLAST search. The phylogenetic tree 
was constructed by the neighbor-joining method with the Poisson 
correction model by the software MEGA 5
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The Luria–Bertani (LB) medium was used for plasmid 
construction in E. coli. The M9 medium plus glucose was 
used as the minimum medium for flask fermentations to 
test the physiological characterizations of the engineered 
strains. Tryptophan (50 mg/L) was added in M9 medium 
for all B. subtilis strains. The 5FU medium [39] was used 
for the selection of marker-free engineered colonies of B. 
subtilis. The LBR medium plus glucose as a rich medium 
was used for the high concentration of sugar fermen-
tation, which contained 3  g/L tryptone, 15  g/L yeast 
extract, 3 g/L NaCl, and appropriate glucose. Antibiotics 
were added appropriately (for B. subtilis, chlorampheni-
col 5  mg/mL, erythromycin 3  mg/mL, spectinomycin 
100  mg/mL, neomycin 5  mg/mL; for E. coli, ampicillin 
100  mg/mL; chloramphenicol 15  mg/mL, and spectino-
mycin 100 mg/mL). With the exception of B. subtilis 168, 
5 mg/mL neomycin was added to the medium for all the 
B. subtilis mutants.
Strains were stored at −80 °C and revived by growing 
on LB agar slants/plates. Single colonies were transferred 
into 5 mL LB medium containing the corresponding anti-
biotic when required. All cultivations were performed 
Table 3 Strains and plasmids
a Bacillus Genetic Stock Center
b China Center of Industrial Culture Collection
Name Relevant genotype Source/reference
Strains
 B. subtilis 168 Wide-type strain, trpC2 BGSCa
 E. coli DH5α Invitrogen
K. pneumoniae CICC 10011 CICCb
 BSF1 B. subtilis 168Δupp (Fu et al. [25])
 BSF2 B. subtilis 168ΔuppΔacoA This study
 BSF3 B. subtilis 168ΔuppΔacoAΔbdhA (Fu et al. [25])
 BSF4 B. subtilis 168ΔuppΔacoAΔbdhAΔpta This study
 BSF5 B. subtilis 168ΔuppΔacoAΔbdhAΔptaΔldh This study
 BSF6 B. subtilis 168ΔuppΔacoAΔbdhAΔptaΔldh; P43::alsS-alsD This study
 BSF7 B. subtilis 168ΔuppΔacoAΔbdhAΔptaΔldh; P43::budC, spc This study
 BSF8 B. subtilis 168ΔuppΔacoAΔbdhAΔptaΔldh; P43::alsS-alsD; P43::budC, spc This study
 BSF9 B. subtilis 168ΔuppΔacoAΔbdhAΔptaΔldh; P43::alsS-alsD; P43::alsS-alsD-budC-udhA, erm This study
 BSF17 B. subtilis 168ΔuppΔacoAΔbdhA; pHP13-P43-budC This study
 BSF18 B. subtilis 168ΔuppΔacoAΔbdhA; pHP13-P43-bdhA (Fu et al. [25])
 BSF25 B. subtilis 168ΔuppΔacoAΔbdhA; P43::alsS-alsD-budC-udhA, erm This study
Plasmids
 pUC18 Ampr Lab Stock
 pUC18-uppFB-neo Kanr Lab Stock
 pC194 Cmr, Bacillus cloning vector Lab Stock
 pE194 Emr, Bacillus cloning vector Lab Stock
 pHP13 Cmr, Emr, E. coli–B. subtilis shuttle vector Lab Stock
 pUC18-SP Ampr, Spcr, containing P43 promoter Lab stock
 pUC18-SP-budC Ampr, Spcr, containing P43 promoter and budC This study
 pCU puC18 containing cat-upp cassette Lab stock
 pCU-ptaFB pCU containing pta flanks This study
 pCU-ldhFB pCU containing ldh flanks This study
 pCU-bdhAFB-PSD pCU-bdhAFB containing alsS-alsD under P43 This study
 pUC18-SP-budC Ampr, Spcr, containing budC under P43 promoter This study
 pUC18-P43 Amp
r, Emr, containing P43 promoter This study
 pUC18-P43-SD Amp
r, Emr, containing alsS and alsD under P43 promoter This study
 pUC18-P43-SDU Amp
r, Emr, containing alsS, alsD and udhA under P43 promoter This study
 pUC18-P43-SDBU Amp
r, Emr, containing alsS, alsD, budC, and udhA under P43 promoter This study
 pPSDBUE pUC18-P43-SDBU containing erythromycin resistance gene This study
 pHP13-P43-budC Em
r, Cmr, containing budC under P43 promoter This study
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at 37  °C. After 12-h incubation at 220  rpm, a 2  % (v/v) 
inocula was added to 50 mL M9 medium with 10 g/L glu-
cose or LBR medium with 105 g/L glucose, in a 250-mL 
shake flask and cultivated for 12 h at 220 rpm to prepare 
the M9 or LBR seed, respectively. Cell growth was deter-
mined by measuring turbidity at 600  nm (OD600) using 
a UV–Vis spectrophotometer. This M9 or LBR seed cul-
ture was inoculated appropriately to set an initial OD600 
of 0.05 under cultured conditions for flask fermentation, 
and 100  mL corresponding culture in a 250-mL flask 
with silica gel plug kept agitated at a speed of 100  rpm 
was used for the microaerobic tests. For batch fermenta-
tion, the LBR medium aforementioned was inoculated 
with 100  mL LBR seed culture in a 5-L fermenter (Bai-
lun, Shanghai, China) with an operating volume of about 
2.3  L. All cultivations were carried out at 37  °C with 
different aeration rates. The agitation speed was main-
tained at 300  rpm. The initial pH of the medium was 
6.5, and during the fermentation process, the pH value 
was uncontrolled. The initial glucose concentration was 
~110  g/L. For fed-batch fermentation, the inoculation 
procedure and fermentation conditions were identical 
to that described for batch experiments, and 250-mL 
1000 g/L glucose stock and 5 g yeast extract power were 
added when the residual glucose concentration was 
reduced to about 10 g/L.
Plasmid construction
All primers are listed in Table 4.
For pta (accession number, BG10634) deletion, the 
upstream and downstream fragments (pta-F and pta-B—
forward and backward fragments) were amplified from 
the B. subtilis genome using primers, d-pta-FU/L and 
d-pta-BU/L, respectively. The two fragments were fused 
and amplified by fusion PCR with primers d-pta-FsnU/L. 
The fused fragment (pta-FB) was then digested with 
SphI-KpnI, and was ligated into the same digested sites 
of pCU to create pCU-ptaFB. Using a similar procedure, 
the ldhFB-fused fragments were amplified with corre-
sponding primers for ldh (accession number, BG19003) 
Table 4 Primers used in this study
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deletion. Digested with AatII, the fragment was ligated 
into the corresponding site of pCU to yield plasmid pCU-
ldhFB. For marker-free gene overexpression, the B. sub-
tilis strong promoter P43 and the fragments of alsS and 
alsD genes were amplified together by primers O-P43-U 
and O-alsSD-L from pPSDBUE, and then placed between 
the upstream and downstream fragments of bdhA in 
pCU-bdhAFB, generating pCU-bdhA-PSD for the over-
expression of alsSD in the genome of B. subtilis.
The vector pPSDBUE, for overexpressions of alsS 
(accession number, BG10471), alsD (accession number, 
BG10472), budC (accession number, HM113375), and 
udhA (accession number, EG11428) in the genome of B. 
subtilis by single-crossing event at P43 plot, was built as 
follows. The P43 promoter was amplified from the B. sub-
tilis 168 chromosomal DNA by the primers O-P43-U/L, 
digested with BamHI-SmaI, and ligated to the match-
ing sites of pUC18, yielding pUC18-P43. Then the alsS 
and alsD genes were amplified together by the primers 
O-alsSD-U/L, digested with SmaI-BamHI, and ligated 
to pUC18-P43 that digested with the same enzyme to 
create pUC18-P43-SD. Next, the udhA gene was ampli-
fied using primers O-udhA-U/L, digested with XbaI-SalI 
and ligated to the same sites of pUC18-P43-SD to create 
pUC18-P43-SDU. Subsequently, the budC gene amplified 
by the primers O-budC-U/L was digested with BamHI 
and ligated to the pUC18-P43-SDU digested with the 
same restriction site, yielding pUC18-P43-SDBU. Finally, 
the erythromycin resistance gene erm were amplified 
from the pHP13 by the primers O-em-U/L, and ligated to 
the AatII-digested pUC18-P43-SDBU, yielding pPSDBUE.
The shuttle vectors pHP13-P43-budC was constructed 
for budC overexpression, based on the B. subtilis-E. coli 
shuttle vector pHP13-P43 with the B. subtilis strong pro-
moter P43. The budC was amplified by PCR from K. pneu-
moniae CICC10011 with primers E-budC-U/L. These 
fragments were digested with the restriction sites KpnI-
BamHI, and ligated to KpnI-BamHI digested pHP13-P43, 
yielding pHP13-P43-budC.
The pUC18-SP vector for budC overexpression in the 
genome of B. subtilis can be selected by the spectinomy-
cin. The budC gene was amplified by primers S-budC-
U/L, digested with BamHI-XbaI, and ligated to the 
matching sites of pUC18-SP to create pUC18-SP-budC.
Strains’ construction
The vector pCU-acoAFB (acoA accession number, 
BG12558) was integrated into BSF1 chromosome by the 
first single-crossover recombination, and chlorampheni-
col-resistant transformants were selected and verified by 
PCR. Next, the resulting transformant was cultured in LB 
liquid medium for 12  h, and then the cells were spread 
on a 5FU agar plate. The acoA-deleted strain denoted 
as BSF2 was selected from the grown colonies by PCR 
verification using primers d-acoA-FU/BL. The pta and 
ldh genes were knocked out step by step using the same 
method (Additional file 1: Figure S1), yielding BSF4 and 
BSF5. Subsequently, the plasmid pCU-bdhAFB-PSD 
(bdhA accession number, BG12803) was introduced into 
the BSF5 strain for alsSD operon overexpression using 
the two-step method described above, yielding BSF6 
(Additional file 2: Figure S2).
The shuttle vector for overexpressing the budC was 
transformed into the B. subtilis strains, yielding BSF17. 
The vector pUC18-SP-budC was integrated into the cho-
romosomes of BSF5 and BSF6, yielding BSF7 and BSF8, 
respectively. The vector pPSDBUE was integrated into 
the choromosomes of BSF3 and BSF6 at P43 plot, yielding 
BSF25 and BSF9, respectively.
AR enzyme assay
To determine the levels of AR activities, bacteria were 
cultured in the M9 medium under the microaerobic con-
dition for 20  h during exponential growth. AR activity 
was determined by measuring pyruvate linked NADH 
oxidation at 340  nm as described previously [51, 55], 
except for the reaction temperature set at 37  °C. Cells 
were harvested from 1  mL culture samples by centrifu-
gation for 1 min, and the supernatant was removed. The 
precipitate was then broken in 400 μL 0.1 M phosphate 
buffer (pH =  7.0) by sonication (130  W, 20  kHz, pulse: 
5  s on; 5  s off; total: 20 min) followed by centrifugation 
at 4  °C to remove cell debris. AR activity was assayed 
spectrophotometrically at 37 °C in a total volume of 1 mL 
0.1  M phosphate buffer (pH  =  7) containing 0.2  mM 
NADH and 50  mM AC. The reaction was initiated by 
the addition of 20 μL cell extract and monitored by the 
decrease in absorbance at 340  nm. Total protein con-
centrations were determined according to the Bradford 
method [56].
Detection of metabolites
Cell growth was monitored by measuring optical den-
sity at 600  nm (OD600). Glucose was determined using 
a glucose analyzer. Extracellular metabolite concentra-
tions were determined by HPLC [33]. The mobile phase 
consisted of 5  mM H2SO4 with the flow rate at 0.4  ml/
min, and the column temperature was set at 65  °C. To 
determine the enantiomeric distribution of 2,3-BD, the 
fermentation samples were saturated with sodium chlo-
ride and extracted with ethyl acetate. The isomers in the 
extracts were then analyzed by GC-FID (Hewlett Pack-
ard) equipped with a HP-chiral 20b column as described 
previously [57]. The oven temperature program was as 
follows: 40 °C (2 min), increased to 75 °C (4 min) at 5 °C 
min−1, followed by a ramp of 1 °C min−1 to 80 °C (2 min), 
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and finally, 15 °C min−1 to 230 °C (4 min). The intracel-
lular NADH and NAD+ levels were determined by NAD/
NADH Quantitation Kit (SIGMA).
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